Evidence map›Paper›PMID 37157153›Full record

ArticleHuman vaccines & immunotherapeutics2023

COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study.

Maurice J Chery, Kobel Dubique, Julia M Higgins, Peterson Abnis Faure, Roslyn Phillips, Sarah Morris, Mary Clisbee, Donaldson F Conserve, Tiarney Ricthwood, Ralph M Lefruit and 2 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maurice J CheryResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.ORCID 0000-0002-9380-6649
Kobel DubiqueResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.
Julia M HigginsStrategic Information Systems, Partners in Health, Boston, MA, USA.
Peterson Abnis FaureResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.
Roslyn PhillipsResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.
Sarah MorrisDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.
Mary ClisbeeResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.
Donaldson F ConserveDepartment of Prevention and Community Health, George Washington University School of Public Health and Health Services: The George Washington University Milken Institute of Public Health, Washington, DC, USA.
Tiarney RicthwoodDepartment of Medicine & Community Health and Global Health, Duke Institute of Global Health, Durham, NC, USA.
Ralph M LefruitResearch Department, Zanmi Lasante/Partners in Health Mirebalais: Hopital Universitaire de Mirebalais, Mirebalais, Haiti.
Bethany L Hedt-GauthierDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
, on behalf of the Cross-Site COVID-19 Cohort Technical Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines are the most effective mechanism for ending the COVID-19 pandemic. However, reluctance to accept vaccines has hindered the efforts of health authorities to combat the virus. In Haiti, as of July 2021, less than 1% of the country's population has been fully vaccinated in part due to vaccine hesitancy. Our goal was to assess Haitian attitudes toward COVID-19 vaccination and investigate the primary reasons for Moderna vaccine hesitancy. We conducted a cross-sectional survey across three rural Haitian communities, in September 2021. The research team used electronic tablets to collect quantitative data from 1,071 respondents, selected randomly across the communities. We report descriptive statistics and identify variables associated with vaccine acceptance using logistic regression built using a backward stepwise approach. Among 1,071 respondents, the overall acceptance rate was 27.0% (n = 285). The most common reason for vaccine hesitancy was "concern about side effects" (n = 484, 67.1%) followed by "concern about contracting COVID-19 from the vaccine" (n = 472, 65.4%). Three-quarters of respondents (n = 817) identified their healthcare workers as their most trustworthy source for information related to the vaccine. In the bivariate analysis, male gender (

Indexed as

COVID-19COVID-19 VaccinesCross-Sectional StudiesEthanolHaitiHumansMalePandemicsVaccinationCOVID-19 VaccinesEthanolCOVID-19Haitiimmunizationruralvaccine acceptancevaccine hesitancy

Identifiers

PMID37157153
PMCPMC10171132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.